Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $121.52 USD
Change Today +1.34 / 1.11%
Volume 179.0K
TFX On Other Exchanges
New York
As of 8:04 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

teleflex inc (TFX) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/23/15 - $123.09
52 Week Low
04/28/14 - $99.56
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TELEFLEX INC (TFX)

Related News

No related news articles were found.

teleflex inc (TFX) Related Businessweek News

No Related Businessweek News Found

teleflex inc (TFX) Details

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and taking of blood samples through a single puncture site; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. The company also provides respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand. In addition, it offers surgical products, such as ligation clips and closure products; appliers and sutures used in surgical procedures; access ports for use in minimally invasive laparoscopic surgical procedures; robotic surgery and fluid management products for use in chest drainage; and reusable hand-held instruments for surgical procedures under the Deknatel, Pilling, Pleur-evac, Taut, and Weck brands. Further, the company offers cardiac care products comprising diagnostic catheters, including thermodilution and wedge pressure catheters; specialized catheters; therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Additionally, it provides catheters, urine collectors, catheterization accessories, and products for operative endourology under the Rusch brand name; micro-laparoscopic instrumentation products; and original equipment manufacturing services. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

11,700 Employees
Last Reported Date: 02/20/15
Founded in 1943

teleflex inc (TFX) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $866.7K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $468.6K
Senior Vice President of Global Operations
Total Annual Compensation: $312.2K
Executive Vice President and President of Ame...
Total Annual Compensation: $431.5K
Vice President of Global Human Resources
Total Annual Compensation: $281.8K
Compensation as of Fiscal Year 2014.

teleflex inc (TFX) Key Developments

Teleflex Incorporated to showcase Advanced Interventional Access Solutions at European Vascular Course

Teleflex Incorporated announced that it will showcase its range of interventional products at the 19th European Vascular Course in Maastricht on March 8 - 10, 2015. During the event, Teleflex will highlight its Arrow chronic hemodialysis catheter portfolio, which offers both split-tip and step-tip catheters for both retrograde and antegrade insertion techniques. The Arrow NextStep Retrograde and Antegrade product family consists of step-tip catheters that can easily be inserted and tunneled using retrograde or antegrade technique, respectively. These step-tip catheters also have the advantage of split-tip high flow characteristics. The step-tip on these catheters is designed for smooth, over-the-wire transitions during insertions and exchanges. The Arrow Cannon II Plus and Arrow Edge products are split-tip catheters that can be tunneled using retrograde or antegrade technique, respectively. Teleflex will also highlight the Arrow GPSCath Balloon Dilatation Catheter, which features VisioValve technology. The Arrow GPSCath Catheter is a specialty two-in-one device that is indicated for percutaneous transluminal angioplasty in the peripheral vasculature, including iliac, femoral, popliteal, infrapopliteal and renal arteries.

Teleflex Incorporated Signs New Agreements with Premier, Inc. for Endomechanical Products, Suture and Trocars

Teleflex Incorporated has announced three new group purchasing agreements with Premier Inc. The new agreements cover Teleflex’s Weck brand of Endomechanical (Ligation and Stapling) products, Deknatel brand of Cardiovascular Suture, and Weck Vista brand of Bladeless Laparoscopic Access Ports. The agreements begin April 1, 2015 and extend through March 31, 2018. The Weck Hem-o-lok Polymer Locking Ligation System is designed to give surgeons confidence in clip security. The unique polymer locking clip provides the assurance of secure ‘cold’ ligation during critical nerve-sparing prostatectomy procedures. Weck Vista Bladeless Laparoscopic Access Ports are designed with an asymmetrical dilating tip to help minimize patient trauma. The broad line of access ports includes differentiated products for open access techniques using either balloon or cone ports.

Teleflex Launches Triple-Lumen PICC with Chlorag+ard Technology

Teleflex Incorporated has launched a triple-lumen ARROW peripherally inserted central catheter, or PICC, with Chlorag+ard Technology. Pressure-injectable ARROW PICCs with Chlorag+ard Technology are the world's first FDA-cleared central venous catheters to significantly reduce the risk of central line-associated bloodstream infections (CLABSI) and PICC-related vessel thrombosis, compared to traditional uncoated catheters. They are also the only PICCs in the IV catheter marketplace that have received FDA 510(k) clearance for both broad-spectrum antimicrobial and antithrombogenic protection. Hospitals and clinicians have increasingly focused on reducing CLABSI and catheter-related vessel thrombosis when inserting PICCs, which are widely used in acute-care and long-term care settings. In addition to CLABSI and thrombosis, the ARROW PICC with Chlorag+ard Technology protects against thrombotic, intraluminal catheter occlusion, the most common non-infectious complication in the long-term use of central lines. Occlusions can delay patient therapy and also require the use of expensive de-clotting agents. Chlorag+ard Technology uses a proprietary process to chemically bond chlorhexidine to both the internal and external surfaces of the catheter. The chlorhexidine-bonded surfaces, which provide a controlled release of the broad-spectrum antimicrobial, are the key to the PICC's antimicrobial and antithrombogenic benefits. The FDA clearance for ARROW PICCs with Chlorag+ard Technology states that these IV catheters provide less thrombus accumulation for at least 30 days. In Vitro data establishes that the device provides 99.99% colonization reduction against gram + and gram - bacteria and fungi for at least 30 days.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TFX:US $121.52 USD +1.34

TFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ansell Ltd A$28.35 AUD +0.84
Donaldson Co Inc $37.74 USD +0.08
PerkinElmer Inc $51.51 USD +0.52
STERIS Corp $69.70 USD +0.56
West Pharmaceutical Services Inc $56.37 USD +0.79
View Industry Companies

Industry Analysis


Industry Average

Valuation TFX Industry Range
Price/Earnings 29.3x
Price/Sales 2.7x
Price/Book 2.6x
Price/Cash Flow 26.6x
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELEFLEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at